1.
2.
Acta Derm Venereol
; 98(5): 530-531, 2018 Apr 27.
Article
in English
| MEDLINE
| ID: mdl-29362816
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Imidazoles/adverse effects , Melanoma/drug therapy , Oximes/adverse effects , Protein Kinase Inhibitors/adverse effects , Pyoderma Gangrenosum/chemically induced , Pyridones/adverse effects , Pyrimidinones/adverse effects , Skin Neoplasms/drug therapy , Staphylococcal Infections/chemically induced , Aged , Anti-Bacterial Agents/therapeutic use , Humans , Male , Melanoma/genetics , Melanoma/secondary , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Pyoderma Gangrenosum/diagnosis , Pyoderma Gangrenosum/drug therapy , Pyoderma Gangrenosum/microbiology , Risk Factors , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Staphylococcal Infections/diagnosis , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Treatment Outcome
3.
Acta Derm Venereol
; 97(8): 955-956, 2017 Aug 31.
Article
in English
| MEDLINE
| ID: mdl-28448098
Subject(s)
Cyclosporine/therapeutic use , Dermatitis, Atopic/drug therapy , Immunosuppressive Agents/therapeutic use , Adolescent , Adult , Cyclosporine/adverse effects , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/immunology , Drug Resistance , Female , France , Humans , Immunosuppressive Agents/adverse effects , Male , Remission Induction , Retrospective Studies , Severity of Illness Index , Time Factors , Treatment Outcome , Young Adult
4.